Roche director Suessmuth Dyckerhoff to stand down from board
Published by Global Banking & Finance Review®
Posted on October 3, 2025
1 min readLast updated: January 21, 2026
Published by Global Banking & Finance Review®
Posted on October 3, 2025
1 min readLast updated: January 21, 2026
Claudia Suessmuth Dyckerhoff will not seek re-election to Roche's board, stepping down to join another healthcare board, as announced by Roche.
ZURICH (Reuters) -Roche said on Friday Claudia Suessmuth Dyckerhoff would not stand for re-election as a member of the pharma company's board of directors.
Suessmuth Dyckerhoff, who has been on Roche's board since 2016, is stepping down after being nominated for election to the board of another healthcare company.
(Reporting by John Revill; Editing by Clarence Fernandez)
A board of directors is a group of individuals elected to represent shareholders and oversee the activities of a company, ensuring it operates in the best interest of its stakeholders.
Corporate governance refers to the systems and processes that direct and control a company, focusing on the relationships among stakeholders and the goals of the organization.
Explore more articles in the Finance category



